Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
- Marks successful completion of full enrollment of SAD cohorts and the first two MAD cohorts in the healthy volunteer study - Up to 10 adult participants with genetically confirmed Duchenne...
Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and...
Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
- Analysis showed improvement in muscle morphology and increased levels of regeneration in muscle groups, including the diaphragm, quadriceps, and calf - No adverse events and no significant...
- The first healthy volunteer has been dosed in the first component of the Phase 1 study - Initial safety and pharmacokinetic data expected in Q4 2024 - Initiation of the second component of...
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
Dosing of first participant in a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -3.52941176471 | 0.85 | 0.86 | 0.81 | 18314 | 0.83223294 | CS |
| 4 | -0.01 | -1.20481927711 | 0.83 | 0.89 | 0.81 | 108217 | 0.86499106 | CS |
| 12 | 0.07 | 9.33333333333 | 0.75 | 1.32 | 0.67 | 147427 | 0.88105912 | CS |
| 26 | 0.325 | 65.6565656566 | 0.495 | 1.32 | 0.45 | 112065 | 0.76754255 | CS |
| 52 | 0.2 | 32.2580645161 | 0.62 | 1.32 | 0.38 | 90959 | 0.69389415 | CS |
| 156 | 0.2 | 32.2580645161 | 0.62 | 1.32 | 0.38 | 90959 | 0.69389415 | CS |
| 260 | 0.2 | 32.2580645161 | 0.62 | 1.32 | 0.38 | 90959 | 0.69389415 | CS |
WOW23P
4 minutos hace
tweedking
5 minutos hace
jhdf51
5 minutos hace
kazzy
6 minutos hace
georgie18
6 minutos hace
3331
6 minutos hace
Preciouslife1
7 minutos hace
dinogreeves
7 minutos hace
1manband
8 minutos hace
dukeb
8 minutos hace
fuagf
8 minutos hace
johnydollar
11 minutos hace
kazzy
11 minutos hace
stockinspector
12 minutos hace
SCAMBUSTERKING
12 minutos hace
SCAMBUSTERKING
12 minutos hace
weedtrader420
13 minutos hace
weedtrader420
14 minutos hace
dinogreeves
14 minutos hace
DTGoody
15 minutos hace
ddls
15 minutos hace
dinogreeves
16 minutos hace
Chipaway
16 minutos hace
tulla236a
17 minutos hace
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
